Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SITC 2022 | What are you most looking forward to at SITC 2022?

Cristina Puig Saus • 31 Oct 2022
SITC 2022
General

Cristina Puig Saus, PhD, University of California, Los Angeles, talks on what she is most looking forward to at the 37th Annual Meeting of the Society for Immunotherapy in Cancer (SITC 2022), including discussing with colleagues on new exciting projects. This interview took place at the 37th Annual Meeting of the Society for Immunotherapy in Cancer (SITC 2022) in Boston, MA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Cristina Puig Saus

2:16
Landscape analysis of neoepitope-specific T-cell responses depending on clinical benefit from ICIs
Cristina Puig Saus • 31 Oct 2022
2:01
Developing novel T-cell therapeutics for patients with melanoma who do not respond to ICI’s
Cristina Puig Saus • 31 Oct 2022

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals